Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison

Author:

Villela Daniel12,Leonhardt Julia2,Patel Neal3,Joseph Jason3,Kirsch Sebastian2,Hallberg Anders4,Unger Thomas5,Bader Michael6,Santos Robson A.1,Sumners Colin3,Steckelings U. Muscha27

Affiliation:

1. Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil

2. Center for Cardiovascular Research, Institute of Pharmacology, Charité–Medical Faculty Berlin, Berlin, Germany

3. Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, U.S.A.

4. Department of Medicinal Chemistry, University of Uppsala, Uppsala, Sweden

5. CARIM, Maastricht University, Maastricht, The Netherlands

6. Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany

7. IMM–Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark

Abstract

The angiotensin type 2 receptor (AT2R) and the receptor Mas are components of the protective arms of the renin–angiotensin system (RAS), i.e. they both mediate tissue protective and regenerative actions. The spectrum of actions of these two receptors and their signalling mechanisms display striking similarities. Moreover, in some instances, antagonists for one receptor are able to inhibit the action of agonists for the respective other receptor. These observations suggest that there may be a functional or even physical interaction of both receptors. This article discusses potential mechanisms underlying the phenomenon of blockade of angiotensin-(1–7) [Ang-(1–7)] actions by AT2R antagonists and vice versa. Such mechanisms may comprise dimerization of the receptors or dimerization-independent mechanisms such as lack of specificity of the receptor ligands used in the experiments or involvement of the Ang-(1–7) metabolite alamandine and its receptor MrgD in the observed effects. We conclude that evidence for a functional interaction of both receptors is strong, but that such an interaction may be species- and/or tissue-specific and that elucidation of the precise nature of the interaction is only at the very beginning.

Publisher

Portland Press Ltd.

Subject

General Medicine

Reference76 articles.

1. The renin–angiotensin–aldosterone system;Steckelings,2008

2. Key advances in antihypertensive treatment;Paulis;Nat. Rev. Cardiol.,2012

3. Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders;Krum;J. Hypertens.,2007

4. International union of pharmacology. XXIII. The angiotensin II receptors;De Gasparo;Pharmacol. Rev.,2000

5. Discovery and characterization of alamandine: a novel component of the renin–angiotensin system;Lautner;Circ. Res.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3